Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

Seminars in Thrombosis and Hemostasis

Volumn 17, Issue 3, 1991, Pages 303-312

  Janicke, F ^a   Schmitt, M ^a   Graeff, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE;

EID: 0025995880     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1002624     Document Type: Conference Paper

References (0)